Skip to main content
Log in

Transcriptional control and signal transduction, cell cycle

Nucleolin promotes Wnt signaling in human hematopoietic stem/progenitor cells

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Grinstein E, Wernet P. Cellular signalling in normal and cancerous stem cells. Cell Signal. 2007;19:2428–33.

    Article  CAS  Google Scholar 

  2. Fujiki H, Watanabe T, Suganuma M. Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands. J Cancer Res Clin Oncol. 2014;140:689–99.

    Article  CAS  Google Scholar 

  3. Mahotka C, Bhatia S, Kollet J, Grinstein E. Nucleolin promotes execution of the hematopoietic stem cell gene expression program. Leukemia. 2018;32:1865–8.

    Article  CAS  Google Scholar 

  4. Bhatia S, Reister S, Mahotka C, Meisel R, Borkhardt A, Grinstein E. Control of AC133 / CD133 and impact on human hematopoietic progenitor cells through nucleolin. Leukemia. 2015;29:2208–20.

    Article  CAS  Google Scholar 

  5. Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J. 2012;31:2714–36.

    Article  CAS  Google Scholar 

  6. Ratajczak MZ. Spotlight series on stem cell mobilization: many hands on the ball, but who is the quarterback? Leukemia. 2010;24:1665–6.

    Article  CAS  Google Scholar 

  7. Luis TC, Ichii M, Brugman MH, Kincade P, Staal FJT. Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development. Leukemia. 2012;26:414–21.

    Article  CAS  Google Scholar 

  8. McCubrey JA, Steelman L, Bertrand FE, Davis NM, Abrams SL, Montalto G, et al. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia. 2014;28:15–33.

    Article  CAS  Google Scholar 

  9. Zylbersztejn F, Flores-Violante M, Voeltzel T, Nicolini FE, Lefort S, Maguer-Satta V. The BMP pathway: a unique tool to decode origin and progression of leukemia. Exp Hematol. 2018;61:36–4.

    Article  CAS  Google Scholar 

  10. Luis T, Naber B, Fibbe W, van Dongen J, Staal FJT. Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling. Blood. 2010;116:496–7.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was funded, PI E. Grinstein, by Deutsche Forschungsgemeinschaft, grant GR 3581/2-1, and José Carreras Leukämie-Stiftung, grant DJCLS R 12/32.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edgar Grinstein.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reister, S., Mahotka, C., van den Höfel, N. et al. Nucleolin promotes Wnt signaling in human hematopoietic stem/progenitor cells. Leukemia 33, 1052–1054 (2019). https://doi.org/10.1038/s41375-019-0401-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41375-019-0401-4

  • Springer Nature Limited

This article is cited by

Navigation